Half-year report · HY
7446.TEDINET S100Y3KO
Period2025-10-01 → 2026-03-31
Filed2026-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥18.9bn | 2025-10-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥34.4bn | 2024-10-01 → 2025-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥17.8bn | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Operating income | ¥530m | 2025-10-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥325m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥565m | 2025-10-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥595m | 2024-10-01 → 2025-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥355m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥576m | 2025-10-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥400m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥396m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥429m | 2024-10-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥269m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥400m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥273m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥20.4bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥18.4bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥18.5bn | at 2025-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥11.8bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥10.4bn | at 2025-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥8.5bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥8.0bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥7.7bn | at 2025-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.7bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥925m | at 2025-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.7bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥911m | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥745m | at 2024-09-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.9bn | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥150m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥674m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥33m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥19m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥62m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥53m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥439.52 | 2025-10-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥475.93 | 2024-10-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥298.4 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 41.5% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.0% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 16
| Segment | Item | Period | Value |
|---|---|---|---|
| Academia Life Science Sales Groupreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥1.3bn |
| Academia Life Science Sales Groupreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥1.3bn |
| Industry Sales Groupreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥9.6bn |
| Industry Sales Groupreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥9.6bn |
| Medical Sales Groupreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥8.0bn |
| Medical Sales Groupreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥8.0bn |
| —segment total | revenue | 2025-10-01 → 2026-03-31 | ¥18.9bn |
| —segment total | revenue external | 2025-10-01 → 2026-03-31 | ¥18.9bn |
| Academia Life Science Sales Groupreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥1.5bn |
| Academia Life Science Sales Groupreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥1.5bn |
| Industry Sales Groupreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥9.1bn |
| Industry Sales Groupreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥9.1bn |
| Medical Sales Groupreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥7.2bn |
| Medical Sales Groupreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥7.2bn |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥17.8bn |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥17.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 510
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of property plant and equipment inv cf | Prior1InterimDuration | -5470000 | JPY |
| Purchase of property plant and equipment inv cf | InterimDuration | -13686000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | Prior1InterimDuration | 80014000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | InterimDuration | － | JPY |
| Payments for retirement of property plant and equipment inv cf | Prior1InterimDuration | － | JPY |
| Payments for retirement of property plant and equipment inv cf | InterimDuration | -397000 | JPY |
| Purchase of intangible assets inv cf | Prior1InterimDuration | － | JPY |
| Purchase of intangible assets inv cf | InterimDuration | -13000000 | JPY |
| Purchase of investment securities inv cf | Prior1InterimDuration | -16414000 | JPY |
| Purchase of investment securities inv cf | InterimDuration | -17963000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1InterimDuration | － | JPY |
| Proceeds from sales of investment securities inv cf | InterimDuration | 13710000 | JPY |
| Payments into time deposits inv cf | Prior1InterimDuration | -8000000 | JPY |
| Payments into time deposits inv cf | InterimDuration | -8000000 | JPY |
| Proceeds from withdrawal of time deposits inv cf | Prior1InterimDuration | 8000000 | JPY |
| Proceeds from withdrawal of time deposits inv cf | InterimDuration | 8000000 | JPY |
| Purchase of insurance funds inv cf | Prior1InterimDuration | -2330000 | JPY |
| Purchase of insurance funds inv cf | InterimDuration | -2330000 | JPY |
| Other net inv cf | Prior1InterimDuration | 6345000 | JPY |
| Other net inv cf | InterimDuration | 1113000 | JPY |
| Net cash provided by used in investment activities | Prior1InterimDuration | 62144000 | JPY |
| Net cash provided by used in investment activities | InterimDuration | -32554000 | JPY |
| Increase in short term loans payable fin cf | Prior1InterimDuration | 2031000000 | JPY |
| Increase in short term loans payable fin cf | InterimDuration | 2220000000 | JPY |
| Decrease in short term loans payable fin cf | Prior1InterimDuration | -1888000000 | JPY |
| Decrease in short term loans payable fin cf | InterimDuration | -2123000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1InterimDuration | -14340000 | JPY |
| Repayment of long term loans payable fin cf | InterimDuration | -14340000 | JPY |
| Cash dividends paid fin cf | Prior1InterimDuration | -93959000 | JPY |
| Cash dividends paid fin cf | InterimDuration | -112568000 | JPY |
| Purchase of treasury stock fin cf | Prior1InterimDuration | － | JPY |
| Purchase of treasury stock fin cf | InterimDuration | -206000 | JPY |
| Repayments of lease obligations fin cf | Prior1InterimDuration | -28216000 | JPY |
| Repayments of lease obligations fin cf | InterimDuration | -22627000 | JPY |
| Net cash provided by used in financing activities | Prior1InterimDuration | 6484000 | JPY |
| Net cash provided by used in financing activities | InterimDuration | -52743000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1InterimDuration | 742818000 | JPY |
| Net increase decrease in cash and cash equivalents | InterimDuration | 2788838000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 744586000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 910596000 | JPY |
| Cash and cash equivalents | Prior1InterimInstant | 1487404000 | JPY |
| Cash and cash equivalents | InterimInstant | 3699435000 | JPY |
| Salaries and allowances sga | Prior1InterimDuration | 735222000 | JPY |
| Salaries and allowances sga | InterimDuration | 713819000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1InterimDuration | -1077000 | JPY |
| Provision of allowance for doubtful accounts sga | InterimDuration | -983000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 57030000 | JPY |
| Provision for bonuses sga | InterimDuration | 58640000 | JPY |
| Retirement benefit expenses sga | Prior1InterimDuration | 17978000 | JPY |
| Retirement benefit expenses sga | InterimDuration | 9161000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |